Expression of the B subunit of the heat-labile enterotoxin of Escherichia coli in tobacco mosaic virus-infected Nicotiana benthamiana plants and its characterization as mucosal immunogen and adjuvant

Journal of Immunological Methods

Volumn 287, Issue 1-2, 2004, Pages 203-215

  Wagner, Birgit ^a   Hufnagl, Karin ^a   Radauer, Christian ^a   Wagner, Stefan ^a   Baier, Karin ^a   Scheiner, Otto ^a   Wiedermann, Ursula ^a   Breiteneder, Heimo ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

5 bromo 4 chloro 3 indolylphosphate; BCIP; Bovine serum albumin; BSA; Cholera toxin; Con A; Concanavalin A; CT; ELISA; Latex allergen Hev b 3; Mouse model; Mucosal adjuvant; Nicotiana benthamiana; Recombinant LTB; Tobacco mosaic virus expression vector

Indexed keywords

ALLERGEN; BACTERIAL PROTEIN; ENTEROTOXIN; GANGLIOSIDE GM1; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOLOGICAL ADJUVANT; LATEX; RECOMBINANT DNA; VIRUS DNA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG SCREENING; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; HUMORAL IMMUNITY; IMMUNOBLOTTING; IMMUNOGENICITY; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH2 CELL; TOBACCO; TOBACCO MOSAIC VIRUS; VIRUS EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACTERIAL TOXINS; CLONING, MOLECULAR; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI PROTEINS; POLYMERASE CHAIN REACTION; RNA; TOBACCO; TOBACCO MOSAIC VIRUS; VACCINES, SYNTHETIC;

BOVINAE; ESCHERICHIA; ESCHERICHIA COLI; HEVEA; NICOTIANA; NICOTIANA BENTHAMIANA; NICOTIANA TABACUM; TOBACCO MOSAIC VIRUS; VECTORS;

EID: 1942488293     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.02.001     Document Type: Article

References (49)

1. Arakawa T., Chong D.K., Merritt J.L., Langridge W.H. Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic Res. 6:1997;403.
2. Bourguin I., Chardes T., Bout D. Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice. Infect. Immun. 61:1993;2082.
3. Clements J.D., Flint D.C., Engert R.F., Klipstein F.A. Cloning and molecular characterization of the B subunit of Escherichia coli heat-labile enterotoxin. Infect. Immun. 40:1983;653.
4. Clements J.D., Hartzog N.M., Lyon F.L. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine. 6:1988;269.
5. de Haan L., Verweij W., Agsteribbe E., Wilschut J. The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin. Immunol. Cell Biol. 76:1998;270.
6. de Haan L., Verweij W.R., Feil I.K., Holtrop M., Hol W.G., Agsteribbe E., Wilschut J. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit. Immunology. 94:1998;424.
7. Dirnberger D., Steinkellner H., Abdennebi L., Remy J.J., van de Wiel D. Secretion of biologically active glycoforms of bovine follicle stimulating hormone in plants. Eur. J. Biochem. 268:2001;4570.
8. Douce G., Fontana M., Pizza M., Rappuoli R., Dougan G. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. Infect. Immun. 65:1997;2821.
9. Douce G., Giuliani M.M., Giannelli V., Pizza M.G., Rappuoli R., Dougan G. Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli. Vaccine. 16:1998;1065.
10. Elson C.O., Ealding W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132:1984;2736.
11. Fromantin C., Jamot B., Cohen J., Piroth L., Pothier P., Kohli E. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response. J. Virol. 75:2001;11010.
12. Gill D.M., Evan D.J. Jr., Evans D.G. Mechanism of activation of adenylate cyclase in vitro by polymyxin-released, heat-labile enterotoxin of Escherichia coli. J. Infect. Dis. 133:1976;103. (Suppl.).
13. Haq T.A., Mason H.S., Clements J.D., Arntzen C.J. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science. 268:1995;714.
14. Hirst T.R., Holmgren J. Conformation of protein secreted across bacterial outer membranes: a study of enterotoxin translocation from Vibrio cholerae. Proc. Natl. Acad. Sci. U. S. A. 84:1987;7418.
15. Kozak M. Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res. 9:1981;5233.
16. Krebitz M., Wiedermann U., Essl D., Steinkellner H., Wagner B., Turpen T.H., Ebner C., Scheiner O., Breiteneder H. Rapid production of the major birch pollen allergen Bet v 1 in Nicotiana benthamiana plants and its immunological in vitro and in vivo characterization. FASEB J. 14:2000;1279.
17. Krebitz M., Wagner B., Ferreira F., Peterbauer C., Campillo N., Witty M., Kolarich D., Steinkellner H., Scheiner O., Breiteneder H. Plant-based heterologous expression of Mal d 2, a thaumatin-like protein and allergen of apple (Malus domestica), and its characterization as an antifungal protein. J. Mol. Biol. 329:2003;721.
18. Lauterslager T.G., Florack D.E., van der Wal T.J., Molthoff J.W., Langeveld J.P., Bosch D., Boersma W.J., Hilgers L.A. Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine. 19:2001;2749.
19. Lim A.A., Tachibana S., Watanabe Y., Wong S.M. Expression and purification of a neuropeptide nocistatin using two related plant viral vectors. Gene. 289:2002;69.
20. Lycke N., Tsuji T., Holmgren J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 22:1992;2277.
21. Marinaro M., Staats H.F., Hiroi T., Jackson R.J., Coste M., Boyaka P.N., Okahashi N., Yamamoto M., Kiyono H., Bluethmann H.et al. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155:1995;4621.
22. Mason H.S., Haq T.A., Clements J.D., Arntzen C.J. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine. 16:1998;1336.
23. McGhee J.R., Mestecky J., Dertzbaugh M.T., Eldridge J.H., Hirasawa M., Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 10:1992;75.
24. Millar D.G., Hirst T.R., Snider D.P. Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its vlosely related homologue, the B subunit of cholera toxin. Infect. Immun. 69:2001;3476.
25. Munro S., Pelham H.R. A C-terminal signal prevents secretion of luminal ER proteins. Cell. 48:1987;899.
26. Nashar T.O., Webb H.M., Eaglestone S., Williams N.A., Hirst T.R. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc. Natl. Acad. Sci. U. S. A. 93:1996;226.
27. Pizza M., Giuliani M.M., Fontana M.R., Monaci E., Douce G., Dougan G., Mills K.H., Rappuoli R., Del Giudice G. Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine. 19:2001;2534.
28. Pogue G.P., Lindbo J.A., Dawson W.O., Turpen T.H. Tobamovirus transient expression vectors: tools for plant biology and high-level expression of foreign proteins in plants. Gelvin S.B., Schilperoort R.A. Plant Molecular Biology Manual. 1998;1 Kluwer Academic Publishers, Dordrecht, The Netherlands.
29. Reuman P.D., Keely S.P., Schiff G.M. Similar subclass antibody responses after intranasal immunization with UV-inactivated RSV mixed with cholera toxin or live RSV. J. Med. Virol. 35:1991;192.
30. Shivprasad S., Pogue G.P., Lewandowski D.J., Hidalgo J., Donson J., Grill L.K., Dawson W.O. Heterologous sequences greatly affect foreign gene expression in tobacco mosaic virus-based vectors. Virology. 255:1999;312.
31. Snider D.P., Marshall J.S., Perdue M.H., Liang H. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J. Immunol. 153:1994;647.
32. Tacket C.O., Mason H.S., Losonsky G., Clements J.D., Levine M.M., Arntzen C.J. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. 4:1998;607.
33. Taguchi T., McGhee J.R., Coffman R.L., Beagley K.W., Eldridge J.H., Takatsu K., Kiyono H. Analysis of Th1 and Th2 cells in murine gut-associated tissues. Frequencies of CD4+ and CD8+ T cells that secrete IFN-gamma and IL-5. J. Immunol. 145:1990;68.
34. Takahashi I., Marinaro M., Kiyono H., Jackson R.J., Nakagawa I., Fujihashi K., Hamada S., Clements J.D., Bost K.L., McGhee J.R. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J. Infect. Dis. 173:1996;627.
35. Tamura S., Asanuma H., Tomita T., Komase K., Kawahara K., Danbara H., Hattori N., Watanabe K., Suzuki Y., Nagamine T.et al. Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. Vaccine. 12:1994;1083.
36. Tamura S., Shoji Y., Hasiguchi K., Aizawa C., Kurata T. Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin. Vaccine. 12:1994;1238.
37. Tochikubo K., Isaka M., Yasuda Y., Kozuka S., Matano K., Miura Y., Taniguchi T. Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin. Vaccine. 16:1998;150.
38. Turpen T.H., Reinl S.J., Charoenvit Y., Hoffman S.L., Fallarme V., Grill L.K. Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus. Biotechnology (NY). 13:1995;53.
39. Verweij W.R., de Haan L., Holtrop M., Agsteribbe E., Brands R., van Scharrenburg G.J., Wilschut J. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen. Vaccine. 16:1998;2069.
40. Wagner B., Krebitz M., Buck D., Niggemann B., Yeang H.Y., Han K.H., Scheiner O., Breiteneder H. Cloning, expression, and characterization of recombinant Hev b 3, a Hevea brasiliensis protein associated with latex allergy in patients with spina bifida. J. Allergy Clin. Immunol. 104:1999;1084.
41. Walmsley A.M., Arntzen C.J. Plants for delivery of edible vaccines. Curr. Opin. Biotechnol. 11:2000;126.
42. Weiner H.L. Oral tolerance. Proc. Natl. Acad. Sci. U. S. A. 91:1994;10762.
43. Wiedermann U., Jahn-Schmid B., Fritsch R., Bauer L., Renz H., Kraft D., Ebner C. Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen. Clin. Exp. Immunol. 111:1998;144.
44. Wiedermann U., Jahn-Schmid B., Bohle B., Repa A., Renz H., Kraft D., Ebner C. Suppression of antigen-specific T-and B-cell responses by intranasal or oral administration of recombinant Bet v 1, the major birch pollen allergen, in a murine model of type I allergy. J. Allergy Clin. Immunol. 103:1999;1202.
45. Williams N.A. Immune modulation by the cholera-like enterotoxin B-subunits: from adjuvant to immunotherapeutic. Int. J. Med. Microbiol. 290:2000;447.
46. Winkler B., Baier K., Wagner S., Repa A., Eichler H.G., Scheiner O., Kraft D., Wiedermann U. Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin. Exp. Allergy. 32:2002;30.
47. Xu-Amano J., Kiyono H., Jackson R.J., Staats H.F., Fujihashi K., Burrows P.D., Elson C.O., Pillai S., McGhee J.R. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1993;1309.
48. Yusibov V., Shivprasad S., Turpen T.H., Dawson W., Koprowski H. Plant viral vectors based on tobamoviruses. Curr. Top. Microbiol. Immunol. 240:1999;81.
49. Yusibov V., Hooper D., Spitsin S., Fleysh N., Kean R., Mikheeva T., Deka D., Karasev A., Cox S., Randall J., Koprowski H. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine. 20:2002;3155.